Pancreatic Cancer Research

ResearcherUniversity of Massachusetts Chan Medical SchoolNo recent work listed

David R. Driscoll

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0070-916X; OpenAlex author ID A5006595592. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2016: 2 papers

Papers 2

  1. Activation of WNT/β-Catenin Signaling Enhances Pancreatic Cancer Development and the Malignant Potential Via Up-regulation of Cyr61. First author DOI 10.1016/j.neo.2016.11.004↗
  2. mTORC2 Signaling Drives the Development and Progression of Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-16-0810↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Makoto Sano · 2 shared papers, 2016 · strength 0.10
  2. Brian Joseph Quattrochi · 2 shared papers, 2016 · strength 0.10
  3. Brian C Lewis · 2 shared papers, 2016 · strength 0.10
  4. Tadatoshi Takayama · 1 shared paper, 2016 · strength 0.05
  5. Jun Qing Yu · 1 shared paper, 2016 · strength 0.05
  6. Thomas R. Jeffry Evans · 1 shared paper, 2016 · strength 0.05
  7. Simon T. Barry · 1 shared paper, 2016 · strength 0.05
  8. Aarthi Gopinathan · 1 shared paper, 2016 · strength 0.05
  9. Nabeel M. Bardeesy · 1 shared paper, 2016 · strength 0.05
  10. Yusuke Mizukami · 1 shared paper, 2016 · strength 0.05
  11. Jennifer P. Morton · 1 shared paper, 2016 · strength 0.05
  12. Owen James Sansom · 1 shared paper, 2016 · strength 0.05
  13. Duncan Ian Jodrell · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.